Mettler-Toledo International Inc. (MTD)
NYSE: MTD · Real-Time Price · USD
1,476.72
-9.83 (-0.66%)
Nov 28, 2025, 1:00 PM EST - Market closed
MTD Market Cap
MTD has a market cap or net worth of $30.17 billion as of November 28, 2025. Its market cap has increased by 13.37% in one year.
Market Cap
30.17B
Enterprise Value
32.34B
1-Year Change
13.37%
Ranking
Category
Stock Price
$1,476.72
Market Cap Chart
Since December 1, 1998, MTD's market cap has increased from $1.05B to $30.17B, an increase of 2,766.23%. That is a compound annual growth rate of 13.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 30.17B | 16.82% |
| Dec 31, 2024 | 25.82B | -1.82% |
| Dec 29, 2023 | 26.30B | -18.38% |
| Dec 30, 2022 | 32.23B | -17.40% |
| Dec 31, 2021 | 39.01B | 43.86% |
| Dec 31, 2020 | 27.12B | 40.37% |
| Dec 31, 2019 | 19.32B | 36.39% |
| Dec 31, 2018 | 14.17B | -10.61% |
| Dec 29, 2017 | 15.85B | 44.31% |
| Dec 30, 2016 | 10.98B | 18.36% |
| Dec 31, 2015 | 9.28B | 7.45% |
| Dec 31, 2014 | 8.63B | 19.90% |
| Dec 31, 2013 | 7.20B | 21.58% |
| Dec 31, 2012 | 5.92B | 26.97% |
| Dec 30, 2011 | 4.67B | -6.01% |
| Dec 31, 2010 | 4.96B | 40.07% |
| Dec 31, 2009 | 3.54B | 56.83% |
| Dec 31, 2008 | 2.26B | -44.94% |
| Dec 31, 2007 | 4.10B | 32.44% |
| Dec 29, 2006 | 3.10B | 35.06% |
| Dec 30, 2005 | 2.29B | 2.30% |
| Dec 31, 2004 | 2.24B | 19.43% |
| Dec 31, 2003 | 1.88B | 32.05% |
| Dec 31, 2002 | 1.42B | -31.71% |
| Dec 31, 2001 | 2.08B | -1.20% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |